RI-MUHC trainee wins scholarship from the Société québécoise d’hypertension artérielle
Congratulations to Joseph Mussa!
Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis
A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2
Results of MI4 Emergency COVID-19 Research Funding (Round 2)
RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe
National study to collect data on aging adults’ experiences during COVID-19 pandemic
Christina Wolfson is co-principal investigator on a new national study
Best poster presentation at meeting of the CIHR Drug Safety Effectiveness Network
Congratulations to Marina Machado!
RI-MUHC researchers review diagnostic tests for COVID-19
Study published in the Annals of Internal Medicine
Results of MI4 Emergency COVID-19 Research Funding (Round 1)
RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe
RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19
Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults
COVID-19 coronavirus and tuberculosis: We need a damage control plan
Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic
Maida Sewitch honoured by Canadian Association of Gastroenterology
Epidemiologist who conducted some of the first Canadian studies in colorectal cancer screening has a talent for outreach